Tubastatin A

Catalog No.S8049

For research use only.

Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective against all the other isozymes (1000-fold) except HDAC8 (57-fold). Tubastatin A promotes autophagy and increases apoptosis.

Tubastatin A Chemical Structure

CAS No. 1252003-15-8

Selleck's Tubastatin A has been cited by 79 publications

Purity & Quality Control

Choose Selective HDAC Inhibitors

Other HDAC Products

Biological Activity

Description Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective against all the other isozymes (1000-fold) except HDAC8 (57-fold). Tubastatin A promotes autophagy and increases apoptosis.
Targets
HDAC6 [1]
(Cell-free assay)
15 nM
In vitro

Tubastatin A is selective at all isozymes except HDAC8 and maintains over 1000-fold selectivity against all isoforms excluding HDAC8, where it has approximately 57-fold selectivity. Tubastatin A preferentially induces α-tubulin hyperacetylation at 2.5 μM. Slight induction of histone hyperacetylation is seen for Tubastatin A at 10 μM. Tubastatin A displays dose-dependent protection against homocysteic acid-induced neuronal cell death starting at 5 μM with near complete protection at 10 μM. [1] Tubastatin A (10 μM) induces an increase in acetylated-α-tubulin levels and the restoration of primary cilia expression in the cholangiocarcinoma cell lines (18-fold); and the restoration of primary cilia correlated with downregulated Hedgehog (Hh) and MAPK signaling pathways, as well as decreased cell proliferation rates (in average by 50%) and invasion (by 40%). [2] Tubastatin A shows significant inhibition of TNF-α and IL-6 in LPS stimulated human THP-1 macrophages with an IC50 of 272 nM and 712 nM. Tubastatin A inhibits nitric oxide (NO) secretion in murine Raw 264.7 macrophages dose depenndently with an IC50 of 4.2 μM. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Sf9 NFPXb5NHfW6ldHnvckBie3OjeR?= MXuyJIhzew>? MmToTY5pcWKrdHnvckBw\iCodXzsJIxmdme2aDDoeY1idiC{ZXPvcYJqdmGwdDDOMZRmem2rbnHsJGdUXC22YXfn[YQhUESDQ{[gLFEhfG9iMUKxOUBz\XOrZIXld{kh\XiycnXzd4VlKGmwIIPmPUBk\WyuczDwdoVqdmO3YnH0[YQhf2m2aDDlcpp6dWViZn;scI94\WRiYomg[ox2d3KxZ3XubYMhSXKpLVjpd{1NgXNvTInzLGFkMS2DTVOgd5Vje3S{YYTlJIFl\Gm2aX;uJI1m[XO3cnXkJIFnfGW{IEKgbJJ{KGK7IH\seY9z\XOlZX7j[UBie3OjeTygTWM2OCB;IECuNFA{PSEQvF2u NHP2ZYg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{W0NVM2Pyd-Mke1OFE{PTd:L3G+
Sf9 Mn3MSpVv[3Srb36gZZN{[Xl? NXH5flJqUW6qaXLpeIlwdiCxZjDmeYxtKGynbnf0bEBpfW2jbjDy[YNwdWKrbnHueEBPNXSncn3pcoFtKEeVVD30ZYdo\WRiSFTBR|YhMDFidH:gNVIyPSC{ZYPp[JVmeyliZYjwdoV{e2WmIHnuJJNnQSClZXzsd{B2e2mwZzDSTGsuUyiDYzmtRW1EKGG|IIP1ZpN1emG2ZTDifUBndHWxcnXzZ4Vv[2ViYYPzZZktKEmFNUCgQUAxNjBzMTFOwG0v NUn6XHN[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke1OFE{PTdpPkK3OVQyOzV5PD;hQi=>
Sf9 NUi3N4hbTnWwY4Tpc44h[XO|YYm= NXfMbo9POzBibXnudy=> MoqzTY5pcWKrdHnvckBw\iCodXzsJIxmdme2aDDoeY1idiC{ZXPvcYJqdmGwdDDOMZRmem2rbnHsJGdUXC22YXfn[YQhUESDQ{[g[ZhxemW|c3XkJIlvKGKjY4Xsc5ZqenW|IHnu[oVkfGWmIIPmPUBk\WyuczD1d4lv\yCobIXvdo9o\W6rYzDISGFEKHO3YoP0doF1\SB|IHHmeIVzKDNyIH3pcpMh[nliZnz1c5Jme2OnbnPlJIF{e2G7LDDJR|UxKD1iMD6wNVMh|ryPLh?= Mle4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N|coRjJ7NUS5PFM4RC:jPh?=
Sf9 NVf6eXFUTnWwY4Tpc44h[XO|YYm= NUDvRmNDQTBibXnudy=> NYnJU5F7UW6qaXLpeIlwdiCxZjDmeYxtKGynbnf0bEBpfW2jbjDy[YNwdWKrbnHueEBPNXSncn3pcoFtKEeVVD30ZYdo\WRiSFTBR|Yh\XiycnXzd4VlKGmwIGPmPUBk\WyuczD1d4lv\yCUSFvLLGFkMSCjczDzeYJ{fHKjdHWgZYZ1\XJiOUCgcYlveyCkeTDmcJVwemmvZYTybYMhdWW2aH;kMEBKSzVyIE2gNE4xOTN5IN88UU4> NVrxXmhxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiwN|g{OjRpPkK4NFM5OzJ2PD;hQi=>
Sf9 M3zuPWZ2dmO2aX;uJIF{e2G7 NEnMemQzKGi{cx?= MmPXTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCKRFHDOkBmgHC{ZYPz[YQhcW5iU3[5JINmdGy|IHnuZ5Vj[XSnZDDmc5IhOiCqcoOgeZNqdmdiUljLT{1C[yCobIXvdo9o\W6rYzDzeYJ{fHKjdHWsJGlEPTBiPTCwMlAyPSEQvF2u M{jwNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEC5NlA{Lz5{M{CwPVIxOzxxYU6=
Sf9 M1HDWmZ2dmO2aX;uJIF{e2G7 NXv4T|VnUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEPiCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMwe2Z7IHPlcIx{KHW|aX7nJHJJU0uDYzDhd{B{fWK|dILheIUtKEmFNUCgQUAxNjBzNTFOwG0v M{jvPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|OUC1OlgxLz5{M{mwOVY5ODxxYU6=
Sf9 MU\GeY5kfGmxbjDhd5NigQ>? NFjnV4o6OCCvaX7z MlzmTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCQLYTldo1qdmGuIFfTWE11[WepZXSg[pVtdCCuZX7neIghUESDQ{[g[ZhxemW|c3XkJIlvKGmwc3XjeEBUTjliY3XscJMhfXOrbneg[ox2d3KxZ3XubYMhYk2DTDDhd{B{fWK|dILheIUh[W[2ZYKgPVAhdWmwczDifUBndHWxcnXzZ4Vv[2VvYnHz[YQh[XO|YYmsJGlEPTBiPTCwMlA{ODRizszNMi=> NUC0TmF3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CwPVI{PjdpPkOwNFkzOzZ5PD;hQi=>
HeLaS3 NIrTVHNHfW6ldHnvckBie3OjeR?= NYr3W2FmOTVibXnudy=> NHjEWpZKdmirYnn0bY9vKG:oIFjERWM3KGmwIHj1cYFvKEinTHHTN{Bk\WyuczDwdoVqdmO3YnH0[YQh\m:{IEG1JI1qdnNiZn;scI94\WRiYomgTGRCSy2JbH:gd5Vje3S{YYTlJIFl\Gm2aX;uJI1m[XO3cnXkJIFnfGW{IEOwJJRwKDR3IH3pcpMh[nliRVzJV2EtKEmFNUCgQUAxNjB|MTFOwG0v NIPP[XA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEOzO|MyPyd-MkizN|c{OTd:L3G+
insect cells MkfWSpVv[3Srb36gZZN{[Xl? NEfReHc1KGi{cx?= NHq2fW5KdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IFjERWM3KGW6cILld5Nm\CCrbjDiZYN2dG:4aYL1d{Bqdm[nY4Tl[EBqdnOnY4SgZ4VtdHNidYPpcochSkGWQ2CgZZMhe3Wkc4TyZZRmKGGodHXyJFQhcHK|IHL5JHVJWEyFLVXTTU1OWy:PUzDhcoFtgXOrczygTWM2OCB;IECuNFM1QSEQvF2u NWnsV5RXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke2OVA6OjVpPkK3OlUxQTJ3PD;hQi=>
SHSY5Y NFPSdnhHfW6ldHnvckBie3OjeR?= NULxPZhzQCCqcoO= MmDBTY5pcWKrdHnvckBw\iCKRFHDOkBqdiCqdX3hckBUUFO\NWmgZ4VtdHNidYPpcochSkGWQ2CgZZMhe3Wkc4TyZZRmKGGodHXyJFghcHK|IHL5JHVJWEyFLVXTTU1OWy:PUzDhcoFtgXOrczygTWM2OCB;IECuNFk1OyEQvF2u M{T2d|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NkWwPVI2Lz5{N{[1NFkzPTxxYU6=
SHSY5Y NVfkdWlQTnWwY4Tpc44h[XO|YYm= NYXMNo44QCCqcoO= NF3zUolKdmirYnn0bY9vKG:oIFjERWMhcW5iaIXtZY4hW0iVWUXZJINmdGy|IIXzbY5oKE2DTDDhd{B{fWK|dILheIUh[W[2ZYKgPEBpenNiYomgWWhRVENvRWPJMW1UN02VIHHuZYx6e2m|LDDJR|UxKD1iMD6xNlIyKM7:TT6= MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzZ3MEmyOUc,Ojd4NUC5NlU9N2F-
Sf9 NWrTR3NbTnWwY4Tpc44h[XO|YYm= NIfFVZI1KGi{cx?= MUHJcohq[mm2aX;uJI9nKG[3bHygcIVv\3SqIHj1cYFvKHKnY3;tZolv[W62IFOteIVzdWmwYXygSmxCTy:KaYOteIFo\2WmIFjERWMyKGW6cILld5Nm\CCrbjDiZYN2dG:4aYL1d{Bqdm[nY4Tl[EB{\jliY3XscJMhfXOrbneg[ox2d3KxZ3XubYMhUESDQzDzeYJ{fHKjdHWgN{Bi\nSncjC0JIhzeyCobIXvdoV{[2WwY3WgZZN{[XluIFnDOVAhRSByLkexPEDPxE1w M3jwWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUS5PFM4Lz5{OUW0PVg{PzxxYU6=
Sf9 MUXGeY5kfGmxbjDhd5NigQ>? MWDJcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEiGQVO4JIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3cz;z[lkh[2WubIOgeZNqdmdiUljLRYNMSWNiYYOgd5Vje3S{YYTlMEBKSzVyIE2gNE45PTRizszNMi=> NXqyXZF1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5NFU3QDBpPkKzPVA2PjhyPD;hQi=>
Sf9 M2O1SWZ2dmO2aX;uJIF{e2G7 NIriUWkyKGi{ Mn;lTY5pcWKrdHnvckBw\iCodXzsJIxmdme2aDDoeY1idiC{ZXPvcYJqdmGwdDDDMZRmem2rbnHsJGZNSUdxSHnzMZRi\2enZDDISGFEOSCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMhcW6oZXP0[YQhe2Z7IHPlcIx{KHW|aX7nJIZtfW:{b3flcolkKEiGQVOgd5Vje3S{YYTlJFMh[W[2ZYKgNUBpeiCobIXvdoV{[2WwY3WgZZN{[XluIFnDOVAhRSByLkm2O{DPxE1w MmDVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3NEm4N|coRjJ7NUS5PFM4RC:jPh?=
SHSY5Y NX3lc|RTTnWwY4Tpc44h[XO|YYm= NHjrT205KGi{cx?= MmHFTY5pcWKrdHnvckBw\iCKRFHDNUBqdiCqdX3hckBUUFO\NWmgZ4VtdHNidYPpcochVU:FUFHDJIF{KHO3YoP0doF1\SCjZoTldkA5KGi{czDifUBWUFCOQz3FV2kuVVNxTWOgZY5idHm|aYOsJGlEPTBiPTCxMlExQTdizszNMi=> NVfmOWc6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke2OVA6OjVpPkK3OlUxQTJ3PD;hQi=>
Sf9 M3\vWmZ2dmO2aX;uJIF{e2G7 MonVN|AhdWmwcx?= MXHJcohq[mm2aX;uJI9nKG[3bHygcIVv\3SqIHj1cYFvKHKnY3;tZolv[W62IFOteIVzdWmwYXygSmxCTy:KaYOteIFo\2WmIFjERWMyKGW6cILld5Nm\CCrbjDiZYN2dG:4aYL1d{Bqdm[nY4Tl[EB{\jliY3XscJMhfXOrbneg[ox2d3KxZ3XubYMhUESDQzDzeYJ{fHKjdHWgN{Bi\nSncjCzNEBucW6|IHL5JIZtfW:{ZYPj[Y5k\SCjc4PhfUwhUUN3MDC9JFEvPTRizszNMi=> MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTV2OUizO{c,Ojl3NEm4N|c9N2F-
Sf9 NFXISY1HfW6ldHnvckBie3OjeR?= M4X0XFkxKG2rboO= NHfQZ41KdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IFOteIVzdWmwYXygTIl{N0[OQVeteIFo\2WmIH\1cIwhdGWwZ4ToJGhFSUNzIHX4dJJme3OnZDDpckBqdnOnY4SgV2Y6KGOnbHzzJJV{cW6pIH\seY9zd2enbnnjJHpOSUxiYYOgd5Vje3S{YYTlJIFnfGW{IEmwJI1qdnNiYomg[ox2d3Knc3PlcoNmNWKjc3XkJIF{e2G7LDDJR|UxKD1iMT65NUDPxE1w NW\SbHBCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CwPVI{PjdpPkOwNFkzOzZ5PD;hQi=>
HCT116 MknQRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NGTlWWc4OiCqcoO= MnX5RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKQ2SxNVYh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEKg{txONg>? M3;GcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NUSxN|U4Lz5{N{W0NVM2PzxxYU6=
HCT116 MmDiRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NHnMRWpCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjDWFEyPiClZXzsd{whUUN3MDC9JFIh|ryPLh?= M3Hjc|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7OUS1O|k2Lz5{OUm0OVc6PTxxYU6=
Sf9 NETYbY5HfW6ldHnvckBie3OjeR?= NFzmbZc{OCCvaX7z M2nRWWlvcGmkaYTpc44hd2ZiZoXscEBt\W6pdHigbJVu[W5icnXjc41jcW6jboSgR{11\XKvaX7hcEBJcXNvdHHn[4VlKEiGQVOzM24ufGW{bXnuZYwhT1OWLYTh[4dm\CCQQ1;SNkApQTVidH:gOFg6KHKnc3nkeYV{MSCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMhcW6oZXP0[YQhe2Z7IHPlcIx{KHW|aX7nJIZtfW:{b3flcolkKEiGQVOgd5Vje3S{YYTlJFMh[W[2ZYKgN|AhdWmwczDifUBndHWxcnXzZ4Vv[2ViYYPzZZktKEmFNUCgQUAzNjJ4IN88UU4> M3fEVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUS5PFM4Lz5{OUW0PVg{PzxxYU6=
HeLa NITRWZJHfW6ldHnvckBie3OjeR?= NVzoPW5YPiCqcoO= NH;qTVFKdmirYnn0bY9vKG:oIFjERWM3KGmwIHj1cYFvKEinTHGgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKEt2MDDofZBmemGlZYT5cIF1cW:wIH;mJIFteGijLYT1ZpVtcW5iaX7jeYJifGWmIH\vdkA3KGi{czDifUBqdW23bn;mcJVwemW|Y3XuZ4Uh[XO|YYmsJGlEPTBiPTCyMlUh|ryPLh?= MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTR3NEK3NEc,OjV2NUSyO|A9N2F-
HL60 NVzmbZVzSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NGPPdWk1QCCqcoO= M2DkXGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFy2NEBk\WyuczDh[pRmeiB2ODDodpMhcW5icILld4Vv[2Vib3[gTmFMOiCrbnjpZol1d3JiQ2nUMVM5PyCkeTDDR2suQCCjc4PhfUwhUUN3MDC9JFIvPTRizszNMi=> MljkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl7NECxNVUoRjJ7OUSwNVE2RC:jPh?=
K562 M4XNfmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MYG0PEBpenN? MlTyRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCNNU[yJINmdGy|IHHmeIVzKDR6IHjyd{BqdiCycnXz[Y5k\SCxZjDKRWszKGmwaHnibZRweiCFWWStN|g4KGK7IFPDT{05KGG|c3H5MEBKSzVyIE2gNk42PCEQvF2u M2K0WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7OUSwNVE2Lz5{OUm0NFEyPTxxYU6=
HEL NWPGc4JkSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M4SySFQ5KGi{cx?= Mn;DRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKRVygZ4VtdHNiYX\0[ZIhPDhiaILzJIlvKHC{ZYPlcoNmKG:oIFrBT|IhcW6qaXLpeI9zKEO\VD2zPFch[nliQ1PLMVgh[XO|YYmsJGlEPTBiPTCyMlU1KM7:TT6= MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2MEGxOUc,Ojl7NECxNVU9N2F-
HeLaS3 NUfuc49vTnWwY4Tpc44h[XO|YYm= MmraNVUhdWmwcx?= MkXrTY5pcWKrdHnvckBw\iCKRFHDNUBqdiCqdX3hckBJ\UyjU{OgZ4VtdHNicILlbY5kfWKjdHXkJIZweiBzNTDtbY5{KG[xbHzve4VlKGK7IFjERWMuT2yxIIP1ZpN1emG2ZTDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB|MDD0c{A1PSCvaX7zJIJ6KEWOSWPBMEBKSzVyIE2gNk44KM7:TT6= MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDN|N{OxO{c,Ojh|M{ezNVc9N2F-
HeLaS3 NVPrNFQ{TnWwY4Tpc44h[XO|YYm= NHjP[HkyPSCvaX7z NIfzRWlKdmirYnn0bY9vKG:oIFjERWM{KGmwIHj1cYFvKEinTHHTN{Bk\WyuczDwdoVqdmO3YnH0[YQh\m:{IEG1JI1qdnNiZn;scI94\WRiYomgTGRCSy2JbH:gd5Vje3S{YYTlJIFl\Gm2aX;uJI1m[XO3cnXkJIFnfGW{IEOwJJRwKDR3IH3pcpMh[nliRVzJV2EtKEmFNUCgQUAzNjlizszNMi=> NXHHUZZGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkizN|c{OTdpPkK4N|M4OzF5PD;hQi=>
Jurkat M3jjdWN6fG:2b4jpZ4l1gSCjc4PhfS=> NFSyd5c4OiCqcoO= NWPlc|RUS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUnW{a3H0JINmdGy|IHHzd4V{e2WmIHHzJIdzd3e2aDDpcohq[mm2aX;uJIFnfGW{IEeyJIhzeyCkeTDNWHMh[XO|YYmsJGlEPTBiPTCzMlM5KM7:TT6= NXv0eWszRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSzNFQ{PDhpPkK0N|A1OzR6PD;hQi=>
MCF7 MXfBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NVvxWlVjPzJiaILz M3u3TWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMz63JO69VS5? M1rMWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NUSxN|U4Lz5{N{W0NVM2PzxxYU6=
MCF7 NVTPfpNxSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= Mn3KRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPQ1[3JINmdGy|LDDJR|UxKD1iMz63JO69VS5? MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2NUe5OUc,Ojl7NEW3PVU9N2F-
HL60 M2DpTmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NV;ReFRbPDhiaILz NXixU4twSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIUFYxKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDDR2suQCCjc4PhfUwhUUN3MDC9JFMvPzVizszNMi=> MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2MEGxOUc,Ojl7NECxNVU9N2F-
K562 MV3BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NE\ySoo1QCCqcoO= MWnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEt3NkKgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KEOFSz24JIF{e2G7LDDJR|UxKD1iMz63OUDPxE1w M3e0SVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7OUSwNVE2Lz5{OUm0NFEyPTxxYU6=
HEL NVvZdGRwSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MXy0PEBpenN? NYridHFbSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDISWwh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IFPDT{05KGG|c3H5MEBKSzVyIE2gN{44PSEQvF2u MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2MEGxOUc,Ojl7NECxNVU9N2F-
HeLaS3 M4jSXGZ2dmO2aX;uJIF{e2G7 MmTSNVUhdWmwcx?= M2\xRWlvcGmkaYTpc44hd2ZiSFTBR|IhcW5iaIXtZY4hUGWOYWOzJINmdGy|IIDy[Ylv[3WkYYTl[EBnd3JiMUWgcYlveyCob3zsc5dm\CCkeTDISGFENUeubzDzeYJ{fHKjdHWgZYRlcXSrb36gcYVie3W{ZXSgZYZ1\XJiM{CgeI8hPDVibXnud{BjgSCHTFnTRUwhUUN3MDC9JFMvQSEQvF2u MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDN|N{OxO{c,Ojh|M{ezNVc9N2F-
CAL27 M3XifmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MWC3NkBpenN? NH72OoxCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFPBUFI4KGOnbHzzJI1m[XO3cnXkJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTC0MlYh|ryPLh?= MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDV6MUK4PUc,Ojh3OEGyPFk9N2F-
PC3 NIj4XVRCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MX23NkBpenN? M4TWPWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOzJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB6Lk[g{txONg>? NFnyXYk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{W0NVM2Pyd-Mke1OFE{PTd:L3G+
PC3 NGfmWoxCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MlTaRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCSQ{OgZ4VtdHNuIFnDOVAhRSB6Lk[g{txONg>? MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2NUe5OUc,Ojl7NEW3PVU9N2F-
Sf9 MmnSSpVv[3Srb36gZZN{[Xl? M4PWTlMxKG2rboO= M4ficWlvcGmkaYTpc44hd2ZiZoXscEBt\W6pdHigbJVu[W5icnXjc41jcW6jboSgR{11\XKvaX7hcEBJcXNvdHHn[4VlKEiGQVOyJIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3czDpcoZm[3SnZDDz[lkh[2WubIOgeZNqdmdiZnz1c5Jw\2WwaXOgTGRCSyC|dXLzeJJifGViMzDh[pRmeiB|MDDtbY5{KGK7IH\seY9z\XOlZX7j[UBie3OjeTygTWM2OCB;IEmuPVch|ryPLh?= MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTV2OUizO{c,Ojl3NEm4N|c9N2F-
MDA-MB-231 NXfnTmFoSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M1GyWVczKGi{cx?= M16zUGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVTBMW1DNTJ|MTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOTBwNDFOwG0v M1K1VFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NUSxN|U4Lz5{N{W0NVM2PzxxYU6=
MDA-MB-231 NF;4NI9CdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NIrTcFFCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1OSi1{M{GgZ4VtdHNuIFnDOVAhRSBzMD60JO69VS5? M{\vdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7OUS1O|k2Lz5{OUm0OVc6PTxxYU6=
Cal27CisR NHvWOYRCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M1fLSFczKGi{cx?= MkPORY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCFYXyyO2Nqe1JiY3XscJMhdWWjc4Xy[YQh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFExNjhizszNMi=> M4\pTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NUixNlg6Lz5{OEW4NVI5QTxxYU6=
LNCAP MYnDfZRwfG:6aXPpeJkh[XO|YYm= NWDaPJU6PzJiaILz NEfvRoFEgXSxdH;4bYNqfHliYXfhbY5{fCCjbnTyc4dmdi2mZYDlcoRmdnRiaIXtZY4hVE6FQWCgZ4VtdHNiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiN{KgbJJ{KGK7IF3UV{Bie3OjeTygTWM2OCB;IEGwMlg5KM7:TT6= NXjFbG92RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSzNFQ{PDhpPkK0N|A1OzR6PD;hQi=>
Cal27CisR M3\6WGZ2dmO2aX;uJIF{e2G7 MmfUNVghcHK| M1rMSGlvcGmkaYTpc44hd2ZiSFTBR{BqdiCqdX3hckBE[Wx{N1Ppd3Ih[2WubIOgeZNqdmdiQn;jMWx6eyincIPpcI9vNUGlKT3BUWMh[XNic4Xid5Rz[XSnIIDy[Ylv[3WkYYTl[EBnd3JiMUigbJJ{KG[xbHzve4VlKGK7IIP1ZpN1emG2ZTDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB|IHjyd{BjgSCobIXvdoV{[2WwY3WgZZN{[XluIFnDOVAhRSBzMj6xJO69VS5? M2n4OVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NUixNlg6Lz5{OEW4NVI5QTxxYU6=
KB MVfDfZRwfG:6aXPpeJkh[XO|YYm= M4CwNFczKGi{cx?= MlnWR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gT2Ih[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UV{Bie3OjeTygTWM2OCB;IEG0MlgyKM7:TT6= NFXXenc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUi5PVM{QCd-MkW4PVk{Ozh:L3G+
THLE2 NUnUe4hyS3m2b4TvfIlkcXS7IHHzd4F6 MVW3NkBpenN? NVWybJNVS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hXEiORUKgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KH[rYXzp[4h1KGOnbHygdJJwdGmoZYLheIlwdiCjc4PhfUwhVEN3MDC9JFE2NjFizszNMi=> NGfrc4U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUW0PVg{Pyd-Mkm1OFk5Ozd:L3G+
CAL27 NGjJdGtHfW6ldHnvckBie3OjeR?= NVu3T|MzOThiaILz NWjnVVJqUW6qaXLpeIlwdiCxZjDISGFEKGmwIHj1cYFvKEODTEK3JINmdGy|IIXzbY5oKEKxYz3MfZMp\XC|aXzvck1C[ylvQV3DJIF{KHO3YoP0doF1\SCycnXpcoN2[mG2ZXSg[o9zKDF6IHjyd{Bnd2yub4fl[EBjgSC|dXLzeJJifGViYXTkbZRqd25ibXXhd5Vz\WRiYX\0[ZIhOyCqcoOgZpkh\my3b4Lld4NmdmOnIHHzd4F6NCCLQ{WwJF0hOTZwMTFOwG0v MnrwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh3OEGyPFkoRjJ6NUixNlg6RC:jPh?=
Sf9 MWLGeY5kfGmxbjDhd5NigQ>? MliyNkBpenN? MWjJcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEiGQVOxJIV5eHKnc4Pl[EBqdiCVZkmgZ4VtdHNiaX7jeYJifGWmIH\vdkAzKGi{czD1d4lv\yCUSFvLMWFkKG[udX;yc4dmdmmlIIP1ZpN1emG2ZTygTWM2OCB;IEG2MlQh|ryPLh?= MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzByOUKwN{c,OjNyMEmyNFM9N2F-
Sf9 Moq0SpVv[3Srb36gZZN{[Xl? NWXhRVNYUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEOSCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMwe2Z7IHPlcIx{KHW|aX7nJHJJU0uDYzDhd{B{fWK|dILheIUtKEmFNUCgQUAyPi52IN88UU4> NHvncGc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mwOVY5OCd-MkO5NFU3QDB:L3G+
B16 MWDHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NXPPUIhiPDhiaILz NFT2ZZRIem:5dHigbY5pcWKrdHnvckBw\iCvb4Xz[UBDOTZiY3XscJMhcW6ldXLheIVlKG[xcjC0PEBpenNiYomgUXRVKGG|c3H5MEBIUTVyIE2gOFAvPSEQvF2u MoXWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMEmyNFMoRjJ|MEC5NlA{RC:jPh?=
KB NWPyOIpHTnWwY4Tpc44h[XO|YYm= NGT6OosyPCC3TR?= MnHBNlQhcHK| M2PwfWlvcGmkaYTpc44hd2ZiSFTBR|EhcW5iaIXtZY4hU0JiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIOEBi[2W2eXzheIlwdiCjdDCxOEB2VSCjZoTldkAzPCCqcoOgZpkhX2W|dHXyckBjdG:2dHnu[{BidmGueYPpdy=> NYfLZZY1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4PVk{OzhpPkK1PFk6OzN6PD;hQi=>
KMS-12-BM MX7GeY5kfGmxbjDhd5NigQ>? MVKxOUB2VQ>? NFfCPFB2eCC2bzC0PEBpenN? NYTr[3dNUW6qaXLpeIlwdiCxZjDISGFEPiCrbjDoeY1idiCNTWOtNVIuSk1iY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZYNmfHmuYYTl[EB1fWK3bHnuJIxmfmWuIHH0JFE2KHWPIIXwJJRwKDR6IHjyd{BjgSCrbX31co9jdG:2IH3leIhw\A>? NGPkNIM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{W0NVM2Pyd-Mke1OFE{PTd:L3G+
MOLM14 NHS2TY9HfW6ldHnvckBie3OjeR?= M4L5d|E2KHWP MlvJeZAhfG9iNEigbJJ{ M3Tv[2lvcGmkaYTpc44hd2ZiSFTBR|YhcW5iaIXtZY4hVU:OTUG0JINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGGlZYT5cIF1\WRidIXieYxqdiCuZY\lcEBifCBzNTD1UUB2eCC2bzC0PEBpenNiYomgbY1ufW6xYnzveEBu\XSqb3S= M{fzS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NUSxN|U4Lz5{N{W0NVM2PzxxYU6=
U937 NVzEbFhLTnWwY4Tpc44h[XO|YYm= NV6zS3R7OiC3TR?= MYexPEBpenN? NUi2WlluUW6qaXLpeIlwdiCxZjDISGFEPiCrbjDoeY1idiCXOUO3JINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGGucHjhMZR2[nWuaX6gZYNmfHmuYYTpc44h[XRiTInzMVQxKHKnc3nkeYUh[XRiMjD1UUBi\nSncjCxPEBpenNiYomgW4V{fGW{bjDicI91KG2ndHjv[C=> M4DJO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6M{O3N|E4Lz5{OEOzO|MyPzxxYU6=
LNCAP NVTHfolFTnWwY4Tpc44h[XO|YYm= NIfTWJkzPCCqcoO= NWnQfphtUW6qaXLpeIlwdiCxZjDISGFEPiCrbjDoeY1idiCOTlPBVEBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIFTIWE1qdmS3Y3XkJIFteGijLYT1ZpVtcW5iZHXhZ4V1gWyjdHnvckBjgSCvZXHzeZJqdmdiaX7jdoVie2ViaX6gZYxxcGFvdIXieYxqdiCjY3X0fYxifGmxbjDt[YF{fXKnZDDh[pRmeiB{NDDodpMhemWuYYTpeoUhfG9iY3;ueJJwdA>? MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzdzN{W0OEc,Ojd5MUe1OFQ9N2F-
human NVHCcndxTnWwY4Tpc44h[XO|YYm= NVz2V5hYOjRiaILz NWXkUGFDSW62YXfvcol{fCCjY4Tpeol1gSCjdDDBVkBqdiCqdX3hckBNVkODUDDj[YxteyCjc4Pld5Nm\CCjczDzeZBxemW|c3nvckBw\iCGSGStbY5lfWOnZDDBVkBxem:2ZXnuJIxmfmWuIH3lZZN2emWmIHHmeIVzKDJ2IHjyd{Bz\WyjdHn2[UB1dyClb370do9t NX7TV5ZmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke3NVc2PDRpPkK3O|E4PTR2PD;hQi=>
DAOY M3fOOJFJXFNiYYPzZZk> MoTrdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKESDT2mgZ4VtdHN? MmrsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SJ-GBM2 MnrNdWhVWyCjc4PhfS=> NInkN5ByUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1qtS2JOOiClZXzsdy=> MljqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
A673 MoWwdWhVWyCjc4PhfS=> M176cJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCDNkezJINmdGy| NUCzdJN7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
SK-N-MC NXLNNFdneUiWUzDhd5NigQ>? NX;WcmVneUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> MlznQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
BT-37 NGP3NpByUFSVIHHzd4F6 MWTxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSlRvM{egZ4VtdHN? MmjoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
NB-EBc1 NI\veIlyUFSVIHHzd4F6 NUjRPJVbeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF7CMWVD[zFiY3XscJM> NHKybVI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
U-2 OS MUjxTHRUKGG|c3H5 NVLXXHdueUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGWtNkBQWyClZXzsdy=> NInFRZo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
Saos-2 NIHh[HByUFSVIHHzd4F6 MljXdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFOjb4OtNkBk\Wyucx?= M2XubVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SK-N-SH NXv0bWhDeUiWUzDhd5NigQ>? Ml7LdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFONLV6tV2gh[2WubIO= MnPvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
NB1643 Mnv6dWhVWyCjc4PhfS=> NGju[HRyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTlKxOlQ{KGOnbHzz NWLyXJpFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
LAN-5 NH;vdotyUFSVIHHzd4F6 NHrkTYFyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTFHOMVUh[2WubIO= NXvCSWFSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh18 NUTBV4NMeUiWUzDhd5NigQ>? MVHxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmhzODDj[Yxtew>? NH\wUZU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
OHS-50 MVzxTHRUKGG|c3H5 MkjadWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE:KUz21NEBk\Wyucx?= MkLDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
RD NIX5R2tyUFSVIHHzd4F6 NY\tNY5GeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGLEJINmdGy| Mm\oQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
Rh30 MW\xTHRUKGG|c3H5 M4fO[ZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCUaEOwJINmdGy| NXjSUmJwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh41 M2nD[ZFJXFNiYYPzZZk> NYDlVmFKeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGLoOFEh[2WubIO= MnO2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
HEL MU\D[YxtKGO7Y3zlJIF{e2G7 M3LSRlEhfG9iNTD1US=> MWm0PEBpenN? M2DYOWNmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJGhGVCClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhTzFicHjhd4Uh[XRiMTD0c{A2KHWPIHHmeIVzKDR6IHjyd{Bxem:yaXTpeY0hcW:maXTlJJN1[WmwaX7nJIJie2WmIH\sc5ch[3m2b33leJJ6 M3T0SlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7OUSwNVE2Lz5{OUm0NFEyPTxxYU6=
HeLa MnfiSpVv[3Srb36gZZN{[Xl? MYqyJJVO NV3FbI9uOTJiaILz MmLDTY5pcWKrdHnvckBw\iCKRFHDOkBqdiCqdX3hckBJ\UyjIHPlcIx{KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIFk\XS7bD30eYJ2dGmwIHzleoVtKGG2IEKgeW0h[W[2ZYKgNVIhcHK|IHL5JHdme3Sncn6gZoxwfCCjbnHsfZNqew>? M17oSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUOzPFc{Lz5{OUWzN|g4OzxxYU6=
HEK293 NHvI[IVHfW6ldHnvckBie3OjeR?= MWGxNEB2VQ>? M1zHNVI1KGi{cx?= NUXGTIxtUW6qaXLpeIlwdiCxZjDISGFEOSCrbjDISWszQTNiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIN{Bi[2W2eXzheIlwdiCjdDCxNEB2VSCjZoTldkAzPCCqcoOgZpkhX2W|dHXyckBjdG:2IH3leIhw\A>? MmDkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh3MkOxNFIoRjJ6NUKzNVAzRC:jPh?=
MV4-11 NEP0XpdHfW6ldHnvckBie3OjeR?= MWqyNFAhdk1? MYCyOEBpenN? Ml70TY5pcWKrdHnvckBw\iCKRFHDOkBqdiCqdX3hckBOXjRvMUGgZ4VtdHNiYYPz[ZN{\WRiYYOgZYNkfW23bHH0bY9vKG:oIHHj[ZR6dGG2ZXSgZYxxcGFvdIXieYxqdiCjdDCyNFAhdk1iYX\0[ZIhOjRiaILzJIJ6KFenc4Tldo4h[myxdDDhcoFtgXOrcx?= NV;mPXFqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm3N|g6PTNpPkK5O|M5QTV|PD;hQi=>
HCT116 NGrkcoFE\WyuIHP5Z4xmKGG|c3H5 NXPqeGN2PSC3TR?= NGGzcGI1QCCqcoO= MXzD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDIR3QyOTZiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KHO3Yj3HNUBxcGG|ZTDheEA2KHWPIHHmeIVzKDR6IHjyd{BjgSCycn;wbYRqfW1iaX;kbYRmKHO2YXnubY5oNWKjc3XkJIZtd3diY4n0c41mfHKrYzDt[ZRpd2R? NHX5[HE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OECzPFMzPCd-MkiwN|g{OjR:L3G+
PC12 MYrO[ZVzd3C{b4TlZ5RqfmViYYPzZZk> MXyxNEB2VQ>? MWeyOEBpenN? MYfO[ZVzd3C{b4TlZ5RqfmViYXP0bZZqfHliYXfhbY5{fCCKMl:yMYlv\HWlZXSgeI95cWOrdImgbY4hemG2IGDDNVIh[2WubIOgZZN{\XO|ZXSgZZMh[2WubDD2bYFjcWyrdImgZZQhOTBidV2gdJJmfHKnYYTl[EBnd3JiMkSgbJJ{KG[xbHzve4VlKGK7IFiyU|Ih[2ijbHzlcodmKGGwZDDt[YF{fXKnZDDh[pRmeiBzMjDodpMh[nliTWTUJIF{e2G7IILlcIF1cX[nIITvJINwdnS{b3y= M3W1fVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyM{i1NlI4Lz5|MEO4OVIzPzxxYU6=
PC12 MkPyUoV2em:ycn;0[YN1cX[nIHHzd4F6 MXy1JJVO MoDINlQhcHK| NWjzNYJqVmW3cn;wdo91\WO2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgOk1QUESDLXnu[JVk\WRidH;4bYNqfHliaX6gdoF1KFCFMUKgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4h[2WubDD2bYFjcWyrdImgZZQhPSC3TTDwdoV1emWjdHXkJIZweiB{NDDodpMh\m:ubH;3[YQh[nliNj3PTGRCKGOqYXzs[Y5o\SCjbnSgcYVie3W{ZXSgZYZ1\XJiMUKgbJJ{KGK7IF3UWEBie3OjeR?= NGPHb|M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEO4OVIzPyd-M{CzPFUzOjd:L3G+
PC12 MkLoUoV2em:ycn;0[YN1cX[nIHHzd4F6 M2nLSlExKHWP NVTRTI1MOjRiaILz NVTReJVpVmW3cn;wdo91\WO2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgOk1QUESDLXnu[JVk\WRidH;4bYNqfHliaX6gdoF1KFCFMUKgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4h[2WubDD2bYFjcWyrdImgZZQhOTBidV2gdJJmfHKnYYTl[EBnd3JiMkSgbJJ{KG[xbHzve4VlKGK7IE[tU2hFSSClaHHscIVv\2ViYX7kJI1m[XO3cnXkJIFnfGW{IEGyJIhzeyCkeTDNWHQh[XO|YYm= Mn3kQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB|OEWyNlcoRjNyM{i1NlI4RC:jPh?=
PC12 NFz0NmlEgXSxcILveIVkfGm4ZTDhd5NigQ>? Mn\FNlQhcHK| M3TnWmN6fG:ycn;0[YN1cX[nIHHjeIl3cXS7IHHnZYlve3RiSELPNk1qdmS3Y3XkJIRidWGpZTDpckBz[XRiUFOxNkBk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiCUT2OgZYNkfW23bHH0bY9vKHC{ZXnuZ5Vj[XSnZDDmc5IhOjRiaILzJIZwdGyxd3XkJIJ6KEh{T{KgZ4hidGynbnflJI1m[XO3cnXkJIFnfGW{IEGyJIhzeyCkeTDER2ZJNUSDIHT5[U1j[XOnZDDmcJVwemW|Y3XuZ4Uh[W6jbInzbZM> NXPnZnF{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CzPFUzOjdpPkOwN|g2OjJ5PD;hQi=>
PC12 M3nRd2N6fG:ycn;0[YN1cX[nIHHzd4F6 NUf3dnlEOjRiaILz M2PuV2N6fG:ycn;0[YN1cX[nIHHjeIl3cXS7IHHnZYlve3RiSELPNk1qdmS3Y3XkJIRidWGpZTDpckBz[XRiUFOxNkBk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiCUT2OgZYNkfW23bHH0bY9vKHC{ZXnuZ5Vj[XSnZDDmc5IhOjRiaILzJIZwdGyxd3XkJIJ6KEh{T{KgZ4hidGynbnflJI1m[XO3cnXkJIFnfGW{IEGyJIhzeyCkeTDER2ZJNUSDIHT5[U1j[XOnZDDpcpZmenSnZDDmcJVwemW|Y3XuZ4UhdWmlcn;zZ49xcWNiYX7hcJl{cXN? NGmxXo49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEO4OVIzPyd-M{CzPFUzOjd:L3G+
PC12 M4DyV25mfXKxcILveIVkfGm4ZTDhd5NigQ>? NF7zUIU2KHSxIEGwJJVO M2TncVI1KGi{cx?= M1rEO25mfXKxcILveIVkfGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IE[tU2hFSS2rbnT1Z4VlKHSxeHnjbZR6KGmwIILheEBRSzF{IHPlcIx{KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJINmdGxidnnhZoltcXS7IHH0JFUhfG9iMUCgeW0heHKndILlZZRm\CCob4KgNlQhcHK|IH\vcIxwf2WmIHL5JFYuV0iGQTDjbIFtdGWwZ3WgZY5lKG2nYYP1doVlKGGodHXyJFEzKGi{czDjc4lv[3WkYYTl[EB4cXSqIHXid4Vt\W5iYomgUXRVKGG|c3H5 NX;aVJlQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CzPFUzOjdpPkOwN|g2OjJ5PD;hQi=>
PC12 M1T3XWFvfGmxeHnkZY51KGG|c3H5 MXe1JJVO NI\N[nAzPCCqcoO= MoT5RY51cW:6aXThcpQh[WO2aY\peJkh[WejaX7zeEBJOk9{LXnu[JVk\WRib4jp[IF1cX[nIIP0doV{eyCrbjDyZZQhWENzMjDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBTV1NiYXPjeY12dGG2aX;uJIF1KDVidV2gdJJmcW6ldXLheIVlKG[xcjCyOEBpenNiZn;scI94\WRiYomgTFJQOiClaHHscIVv\2ViYX7kJI1m[XO3cnXkJIFnfGW{IEGyJIhzeyCkeTDER2ZJNUSDIHT5[U1j[XOnZDDmcJVwemW|Y3XuZ4Uh[W6jbInzbZM> MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODN6NUKyO{c,OzB|OEWyNlc9N2F-
PC12 MULBcpRqd3irZHHueEBie3OjeR?= M1fKdFUhfU1? M2PIb|I1KGi{cx?= Ml7mRY51cW:6aXThcpQh[WO2aY\peJkh[WejaX7zeEBJOk9{LXnu[JVk\WRib4jp[IF1cX[nIIP0doV{eyCrbjDyZZQhWENzMjDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBTV1NiYXPjeY12dGG2aX;uJIF1KDVidV2gdJJmcW6ldXLheIVlKG[xcjCyOEBpenNiZn;scI94\WRiYomgTFJQOiClaHHscIVv\2ViYX7kJI1m[XO3cnXkJIFnfGW{IEGyJIhzeyClb3nuZ5Vj[XSnZDD3bZRpKGWkc3Xs[Y4h[nliRFPGTE1FSSCmeXWtZoF{\WRiZnz1c5Jm NFLvZYo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEO4OVIzPyd-M{CzPFUzOjd:L3G+
Assay
Methods Test Index PMID
Western blot EGFR / p-AKT / AKT / p-ERK / ERK 29665050
Immunofluorescence α-tubulin / Acetylated tubulin ; HDAC6 23798680
In vivo Tubastatin A reduces the growth of cholangiocarcinoma in vivo. Tubastatin A (10 mg/kg) induces a 6-fold lower mean tumor weights in syngeneic rat orthotopic model of cholangiocarcinoma, and reduction of the ratios of tumor weight to liver weight and body weight (5- and 5.6-fold, respectively), as well as a greater frequency of ciliated cholangiocytes compared with controls (29% vs 1.4%). Tubastatin A significantly decreases the amount of PCNA-positive cells in the treated tumors compared with vehicle controls (34% vs 65%). [2] Tubastat A shows significant inhibition of paw volume at 30 mg/kg i.p. in a Freund's complete adjuvant (FCA) induced animal model of inflammation. Tubastat A (30 mg/kg i.p.) significant attenuates clinical scores (~ 70%), and IL-6 expression in paw tissues of collagen induced arthritis DBA1 mouse. [3]

Protocol (from reference)

Kinase Assay:

[4]

  • HDAC enzymatic assays:

    Tubastatin A is dissolved and diluted in assay buffer (50 mM HEPES, pH 7.4, 100 mM KCl, 0.001% Tween-20, 0.05% BSA, and 20 μM tris(2-carboxyethyl)phosphine) to 6-fold of the final concentration. HDAC enzymes are diluted to 1.5-fold of the final concentration in assay buffer and pre-incubated with Tubastatin A for 10 minutes before the addition of the substrate. The amount of FTS (HDAC1, HDAC2, HDAC3, and HDAC6) or MAZ-1675 (HDAC4, HDAC5, HDAC7, HDAC8, and HDAC9) used for each enzyme is equal to the Michaelis constant (Km), as determined by a titration curve. FTS or MAZ-1675 is diluted in assay buffer to 6-fold the final concentration with 0.3 μM sequencing grade trypsin. The substrate/trypsin mix is added to the enzyme/compound mix and the plate is shaken for 60 seconds and then placed into a SpectraMax M5 microtiter plate reader. The enzymatic reaction is monitored for release of 7-amino-4-methoxy-coumarin over 30 minutes, after deacetylation of the lysine side chain in the peptide substrate, and the linear rate of the reaction is calculated.

Cell Research:

[2]

  • Cell lines: Human cholangiocarcinoma cell lines HuCCT-1
  • Concentrations: ~10 μM
  • Incubation Time: 21 days
  • Method:

    Anchorage-independent growth is assessed by growing cells in soft agar. About 25,000 cells suspended in 0.4% agar in culture media are layered over a 1% agar layer in a 6-well plate. Media are added twice a week and pictures are taken after 21 days of incubation. The number and size of colonies are analyzed using the Gel-Pro software.

Animal Research:

[2]

  • Animal Models: Rat cholangiocarcinoma xenografts BDEneu
  • Dosages: 10 mg/kg
  • Administration: i.p. daily

Solubility (25°C)

In vitro

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
5% DMSO+40% PEG 300+5%Tween 80+50% ddH2O
For best results, use promptly after mixing.

1.67mg/mL

Chemical Information

Molecular Weight 335.4
Formula

C20H21N3O2

CAS No. 1252003-15-8
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Frequently Asked Questions

Question 1:
We are planning to order some tubastatin A but I found out there are two versions of it. One has HCl and one does not. Which one do you recommend for live cell use? Will the HCl containing version significantly change the pH?

Answer:
S8049 and S2627 have same molecular structure. The only difference is S2627 containing HCl and has higher solubility in DMSO (74 mg/mL vs. S8049 9 mg/mL). Since they are the same molecule, the biological function should be similar. I would recommend to use S2627 for cell culture study.

Question 2:
What’s the vehicle do you recommend to dissolve the compound for in vivo experiments?

Answer:
S8049 Tubastatin A can be dissolved in 2% DMSO/30% PEG 300/PBS at 2.5 mg/mL as a clear solution, and it is also a clear solution in 2% DMSO/ corn oil at 2.5 mg/mL. The drug in 2% DMSO/0.5% Tween 80/PBS is a homogeneous suspension at 2.5 mg/mL at first. After stay for a while, the precipitation goes out at the bottom of the tube.

Tags: buy Tubastatin A | Tubastatin A supplier | purchase Tubastatin A | Tubastatin A cost | Tubastatin A manufacturer | order Tubastatin A | Tubastatin A distributor